These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2988689)

  • 1. HTLV-III antibodies in a remote population of eastern Zaire.
    Gray RH; Wawer MJ
    Br Med J (Clin Res Ed); 1985 Jun; 290(6482):1662. PubMed ID: 2988689
    [No Abstract]   [Full Text] [Related]  

  • 2. Absence of immunosuppression in healthy subjects from eastern Zaire who are positive for HTLV-III antibody.
    Kestens L; Biggar RJ; Melbye M; Bodner AJ; De Feyter M; Gigase PL
    N Engl J Med; 1985 Jun; 312(23):1517-8. PubMed ID: 2985998
    [No Abstract]   [Full Text] [Related]  

  • 3. Seroepidemiology of HTLV-III antibodies in a remote population of eastern Zaire.
    Biggar RJ; Melbye M; Kestens L; de Feyter M; Saxinger C; Bodner AJ; Paluko L; Blattner WA; Gigase PL
    Br Med J (Clin Res Ed); 1985 Mar; 290(6471):808-10. PubMed ID: 2983820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kaposi's sarcoma in Zaire is not associated with HTLV-III infection.
    Biggar RJ; Melbye M; Kestems L; Sarngadharan MG; de Feyter M; Blattner WA; Gallo RC; Gigase PL
    N Engl J Med; 1984 Oct; 311(16):1051-2. PubMed ID: 6090903
    [No Abstract]   [Full Text] [Related]  

  • 5. Type-I and type-III HTLV antibodies in hospitalized and out-patient Zairians.
    Gazzolo L; Robert-Guroff M; Jennings A; Duc Dodon M; Najberg G; Peti MM; de-Thé G
    Int J Cancer; 1985 Sep; 36(3):373-8. PubMed ID: 2993173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of HTLV-III/LAV in household contacts of patients with confirmed AIDS and controls in Kinshasa, Zaire.
    Mann JM; Quinn TC; Francis H; Nzilambi N; Bosenge N; Bila K; McCormick JB; Ruti K; Asila PK; Curran JW
    JAMA; 1986 Aug; 256(6):721-4. PubMed ID: 3014178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of antibodies to HIV-2/HTLV-4 in six central African nations.
    Kanki PJ; Allan J; Barin F; Redfield R; Clumeck N; Quinn T; Mowovondi F; Thiry L; Burny A; Zagury D
    AIDS Res Hum Retroviruses; 1987; 3(3):317-22. PubMed ID: 2893632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure to detect LAV/HTLV-III antibodies in southeastern Zaire.
    Harms G; Zwingenberger K; Feldmeier H; Bienzle U; Zorr B
    Trans R Soc Trop Med Hyg; 1986; 80(6):1003. PubMed ID: 3474812
    [No Abstract]   [Full Text] [Related]  

  • 9. Human immunodeficiency virus seroprevalence in pediatric patients 2 to 14 years of age at Mama Yemo Hospital, Kinshasa, Zaire.
    Mann JM; Francis H; Davachi F; Baudoux P; Quinn TC; Nzilambi N; Bosenge N; Colebunders RL; Kabote N; Piot P
    Pediatrics; 1986 Oct; 78(4):673-7. PubMed ID: 3020492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to HTLV-I p24 in African and Portuguese populations.
    Larouze B; Schaffar-Deshayes L; Blesonski S; Gaudebout C; Afoutou JM; Couillin P; Da Graca Porto M; Diakhate L; Frelut ML; Jeddi M
    Cancer Res; 1985 Sep; 45(9 Suppl):4630s-4632s. PubMed ID: 2861895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between HTLV-III/LAV infection and tuberculosis in Zaire.
    Mann J; Snider DE; Francis H; Quinn TC; Colebunders RL; Piot P; Curran JW; Nzilambi N; Bosenge N; Malonga M
    JAMA; 1986 Jul; 256(3):346. PubMed ID: 3459897
    [No Abstract]   [Full Text] [Related]  

  • 12. HTLV-III antibody in East Africa.
    N Engl J Med; 1986 Jul; 315(4):259-60. PubMed ID: 3014335
    [No Abstract]   [Full Text] [Related]  

  • 13. Seroepidemiological studies of HTLV-III antibody prevalence among selected groups of heterosexual Africans.
    Clumeck N; Robert-Guroff M; Van de Perre P; Jennings A; Sibomana J; Demol P; Cran S; Gallo RC
    JAMA; 1985 Nov; 254(18):2599-602. PubMed ID: 2997491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The occurrence of LAV/HTLV III antibodies in patients with hemophilia in the County of Funen].
    Larsen FS; Høst A; Munk-Andersen G
    Ugeskr Laeger; 1986 Mar; 148(14):865-7. PubMed ID: 3010526
    [No Abstract]   [Full Text] [Related]  

  • 15. HTLV-I and HTLV-III antibodies and tropical spastic paraparesis.
    Rodgers-Johnson P; Gajdusek DC; Morgan OS; Zaninovic V; Sarin PS; Graham DS
    Lancet; 1985 Nov; 2(8466):1247-8. PubMed ID: 2866324
    [No Abstract]   [Full Text] [Related]  

  • 16. [Research on anti-HTLV-III antibodies: validity of methods].
    Achilli G; Cattaneo E
    Riv Emoter Immunoematol; 1985; 32(2):190-4. PubMed ID: 3003877
    [No Abstract]   [Full Text] [Related]  

  • 17. [High prevalence of anti-LAV/HTLV-III antibodies in a population of heroin addicts from the Nice area].
    Reynes J; Quaranta JF; Pesce A; Bernard E; Fuzibet JG; Maiolini R; Cassuto JP; Dellamonica P
    Presse Med; 1985 Dec; 14(46):2348-9. PubMed ID: 3003734
    [No Abstract]   [Full Text] [Related]  

  • 18. [Anti-HTLV-III/LAV antibodies in hematology reactives].
    Aznar JA; Monzó E; Mayans J; Granda D; Hurtado F; Curats R
    Sangre (Barc); 1986; 31(2):215-7. PubMed ID: 3014670
    [No Abstract]   [Full Text] [Related]  

  • 19. [Significance of anti-HTLV-III antibodies].
    Gerna G
    Riv Emoter Immunoematol; 1985; 32(2):195-7. PubMed ID: 3003878
    [No Abstract]   [Full Text] [Related]  

  • 20. HTLV-III antibodies in human immune gamma-globulin.
    Steele DR
    JAMA; 1986 Feb; 255(5):609. PubMed ID: 2418220
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.